Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study

BACKGROUND: The optimal anticoagulant for end-stage renal disease patients for stroke prophylaxis is unknown. The efficacy and safety of warfarin in this population are debatable. In addition, real-world evidence of direct oral anticoagulants in patients with end-stage renal disease is limited. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Cheng, Chen, Bi-Li, Shih, Chun-Ming, Lin, Feng-Yen, Chen, Chih-Wei, Hsu, Chien-Yi, Kao, Yung-Ta, Bi, Wei-Fung, Chen, Li-Ying, Chien, Li-Nien, Fang, Te-Chao, Huang, Chun-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031437/
https://www.ncbi.nlm.nih.gov/pubmed/33831130
http://dx.doi.org/10.1371/journal.pone.0249940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031437/
https://www.ncbi.nlm.nih.gov/pubmed/33831130
http://dx.doi.org/10.1371/journal.pone.0249940

Ejemplares similares